![](https://porib.com/wp-content/uploads/2021/07/Clinical-Rheumatology-1.jpg)
Navarro F, Martinez-Sesmero JM, Balsa A, Peral C, Montoro M, Valderrama M, Gómez S, de Andrés-Nogales F, Casado MA, Oyagüez I
Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
Clin Reumatol 2020;39:2919-30
![](https://porib.com/wp-content/uploads/2021/07/Clinical-Rheumatology-1.jpg)
Presa M, Pérez-Ruiz F, Oyagüez I